Phthalylsulfathiazole
규격
85-73-4CAS 번호
201-627-4EC 번호
2-[[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]carbamoyl]benzoic acidIUPAC 명칭
C17H13N3O5S2화학식
403.4 g/mol분자량
phthalylsulfathiazole; 85-73-4; Sulfathalidine; Phthalazol; Phthalylsulfonazole; Phthalylsulphathiazole; Sulphaphthalyl; Sulfaphthalazole; Phthalylnorsulfazole; Thalazole; Ftalazol; Phtalylsulfathiazol; Phthalazolum; Ftalilsulfatiazol; Phthalylsulfathiazolum; 4'-(2-Thiazolylsulfamoyl)phthalanilic acid; DTXSID8023470; NSC-66454; NSC-683525; CHEBI:9336; Benzoic acid, 2-(((4-((2-thiazolylamino)sulfonyl)phenyl)amino)carbonyl)-; DTXCID203470; 2-[[4-(thiazol-2-ylsulfamoyl)phenyl]carbamoyl]benzoic acid; 6875L5852V; Benzoic acid, 2-[[[4-[(2-thiazolylamino)sulfonyl]phenyl]amino]carbonyl]-; 2-((4-(thiazol-2-ylsulfamoyl)phenyl)carbamoyl)benzoic acid; ftalilsulfatiazolo; phthalylsulphthiazole; RefChem:174004; A07AB02; 201-627-4; Cremothalidine; Phthalazole; Enteramida; Entexidina; Phtalazol; Intestiazol; Phthalidin; Sulfacetil; Thalistanin; Thalistatyl; Ultratiazol; Ftalysept; Sulftalyl; Taleudron; Talidine; Taloudron; Thalinil; Entero-sulfina; N4-Phthalylsulfathiazole; Ftalil-Esteve; Ftalil-Septol; Phthaloylsulfathiazole; AFI-Ftalyl; 4'-(2-Thiazolylsulfamyl)phthalanilic acid; 2-((4-(N-(Thiazol-2-yl)sulfamoyl)phenyl)carbamoyl)benzoic acid; Ftalylsulfathiazol; 2-(p-N-Phthalylsulfanilyl)aminothiazole; 2-(p-Phthalylaminobenzenesulfamido)thiazole; 2-(N4-Phthalylaminobenzenesulfonamide)thiazole; (o-Carboxybenzoyl)-p-aminophenylsulfonamidothiazole; Phthalylsulfathiazole [INN]; NSC 66454; NSC 683525; 2-[[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]carbamoyl]benzoic acid; 2-({4-[(1,3-thiazol-2-yl)sulfamoyl]phenyl}carbamoyl)benzoic acid; 2-(N(sup4)-Phthalylsulfanilamido)thiazole; 2-(N(sup 4)-Phthalylsulfanilamido)thiazole; MFCD00005318; Phthalanilic acid, 4'-(2-thiazolylsulfamoyl)-; 2-(N(sup 4)-Phthalyaminobenzenesulfonamide)thiazole; 2-(N(sup 4)-Phthalyaminobenzenesulfonamido)thiazole; MLS002693575; Sulfanilamide, N(sup 4)-(o-carboxybenzoyl)-N'-2-thiazolyl-; NSC66454; NSC683525; CAS-85-73-4; NCGC00016337-02; Entexidin; 2-{[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]carbamoyl}benzoic acid; Phthalylsulfathiazole (INN); C17H13N3O5S2; Ftalilsofatiazolo; Ftalilsofatiazolo [DCIT]; 2-[({4-[(1,3-thiazol-2-ylamino)sulfonyl]phenyl}amino)carbonyl]benzoic acid; Ftalylsulfathiazol [Czech]; SMR001233366; Ftalilsulfatiazol [INN-Spanish]; Phtalylsulfathiazol [INN-French]; Phthalylsulfathiazolum [INN-Latin]; SR-05000001793; EINECS 201-627-4; Sulfathalidin;; Colicitina;; AI3-18632; Phthazol;; 85-73-4 (free); phthalylsulfathiazol; UNII-6875L5852V; Prestwick_980; 2-(N4-phthalylsulfanilamido)thiazole; Phthalylsulfathiazole [USP:INN:BAN]; Phthalylsulfhathiazole; Phthalylsulphathiozole; Spectrum_000047; Phthalylsulfathiazole CRS; Prestwick0_000869; Prestwick1_000869; Prestwick2_000869; Prestwick3_000869; Spectrum3_001486; Spectrum4_000154; Spectrum5_001147; 2-[[[4-[(2-Thiazolylamino)sulfonyl]phenyl]amino]carbonyl]benzoic acid; component of Sulfathalidine; Epitope ID:952464; EC 201-627-4; Oprea1_620492; BSPBio_000917; BSPBio_003071; KBioGR_000628; KBioSS_000427; MLS002154042; DivK1c_001029; SCHEMBL152662; SPECTRUM1502021; SPBio_002838; BPBio1_001009; orb1223838; orb1310540; orb3025194; Phthalylsulfathiazole (Standard); CHEMBL1524273; GTPL13907; HMS503M19; HY-B1407R; KBio1_001029; KBio2_000427; KBio2_002995; KBio2_005563; KBio3_002571; MSK4054; PHTHALYLSULFATHIAZOLE [MI]; NINDS_001029; HMS1570N19; HMS1921D22; HMS2092N19; HMS2097N19; HMS2230G21; HMS3374A01; HMS3714N19; HMS5085O13; Pharmakon1600-01502021; HY-B1407; STR05252; Tox21_110380; EBC-26961; MSK4054-100M; NSC758159; PHTHALYLSULFATHIAZOLE [MART.]; s5700; STK730435; WLN: T5N CSJ BMSWR DMVR BVQ; PHTHALYLSULFATHIAZOLE [WHO-DD]; AKOS000745948; MSK4054-1000M; Tox21_110380_1; CCG-212977; CS-4862; DB13248; FP40968; NSC-758159; IDI1_001029; NCGC00016337-01; NCGC00016337-03; NCGC00016337-05; NCGC00094943-01; NCGC00094943-02; AC-19044; ST072020; SBI-0051702.P002; SBI-0051702.P003; DB-056881; PHTHALYLSULFATHIAZOLE [EP MONOGRAPH]; AB00052257; NS00007465; 2-(N4-phthalylaminobenzenesulfonamido)thiazole; C07659; D02440; D78257; AB00052257_08; EN300-18202568; F837430; N-(4-thiazol-2-ylsulfamoyl-phenyl)-phthalamic acid; Q4493189; SR-05000001793-1; SR-05000001793-3; BRD-K64659768-001-04-5; BRD-K64659768-001-12-8; BRD-K64659768-001-13-6; Phthalylsulfathiazole Solution in Methanol, 1000ug/mL; Phthalylsulfathiazole Solution in Methanol, 100ug/mL; Sulfanilamide, N4-(o-carboxybenzoyl)-N'-2-thiazolyl-; Z55165221; N4-Phthalylsulfathiazole, VETRANAL(TM), analytical standard; 2-((4-[(1,3-Thiazol-2-ylamino)sulfonyl]anilino)carbonyl)benzoic acid #; 2-(N-{4-[(1,3-thiazol-2-ylamino)sulfonyl]phenyl}carbamoyl)benzoic acid; 2-[[[4-[(2-Thiazolylamino)sulfonyl]phenyl]amino]carbonyl]-benzoic acid; Phthalylsulfathiazole, European Pharmacopoeia (EP) Reference Standard동의어